In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.
Researchers want to know if irreversible electroporation (IRE) makes it easier for chemotherapy to reach pancreatic cancer cells.
Researchers are testing a new antibody, a type of targeted therapy, in combination with standard treatment for pancreatic cancer in a phase III trial.
A clinical trial tests a precision radiation technique called intensity-modulated radiation therapy against locally advanced pancreatic cancer.
A clinical trial compares intravenous chemotherapy delivery with intra-arterial chemotherapy to see which is more effective for pancreatic cancer.
Dr. Deirdre Cohen discusses clinical trials that aim to improve the effectiveness of immunotherapy for pancreatic cancer.
Multicenter Trial Focuses on Neoadjuvant Treatment for Borderline Resectable and Locally Advanced Disease
Dr. David Ryan outlines a new trial for pre-surgical pancreatic cancer treatment combining a blood pressure drug, immunotherapy, standard care and SBRT.
Stereotactic body radiation therapy (SBRT) is increasingly being used to treat locally advanced pancreatic cancer, and make it surgically removable.